De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis

Phase II and observational studies support the use of rituximab in multiple sclerosis. Standard protocols are lacking, but studies suggest comparable efficacy between low- and high-dose regimens.BACKGROUNDPhase II and observational studies support the use of rituximab in multiple sclerosis. Standard...

Full description

Bibliographic Details

Published in:	Multiple sclerosis Vol. 27; no. 8; p. 1230
Main Authors:	Disanto, Giulio, Ripellino, Paolo, Riccitelli, Gianna C, Sacco, Rosaria, Scotti, Barbara, Fucili, Anita, Pravatà, Emanuele, Kuhle, Jens, Gobbi, Claudio, Zecca, Chiara
Format:	Journal Article
Language:	English
Published:	01.07.2021
ISSN:	1477-0970, 1477-0970
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!